Price to Earnings (P/E)31.6 Beta0.97 Next Earnings Feb 06, 2025 EPS Estimate £1.7 Last Dividend Ex-Date Aug 08, 2024 Dividend Yield2.24% AstraZeneca News The Fly Achilles Therapeutics sells technology assets to AstraZeneca for $12M
Forward Dividend & Yield2.88 (1.95%) Ex-Dividend DateFebruary 23, 2023 1y Target EstN/A AZNCF Valuation Measures Enterprise Value257.22B USD Trailing P/E48.615635 Forward P/EN/A PEG Ratio (5 yr expected)N/A Price/Sales (ttm)5.2764163 ...
Forward Annual Dividend Rate: 2.34 Forward Annual Dividend Yield: 0.0218 Payout Ratio: 0.0308 Ex Dividend Date: 2024-08-08 Pivot, Resistance Levels and Support Levels For Stop Loss and Trading Targets Calculation For Trading: Resistance Level (R3): 10587.33 Resistance Level (R2): 10570.67...
Yield2.28% Dividend78p Ex-Dividend DateAug 8, 2024 Short InterestN/A % of Float ShortedN/A Average Volume2.66M Performance 5 Day -2.03% 1 Month -2.08% 3 Month -12.94% YTD -3.25% 1 Year -1.72% Analyst Ratings Sell Under Hold
Dividend Stocks Latest on AZN:AstraZeneca: Still One Of The Best Big Pharma Picks iREIT®+HOYA Capital 4.8 Hoya Capital Themes: REITs Income Latest on AZN:AstraZeneca: Still One Of The Best Big Pharma Picks (Kody Kester) Ratings Summary ...
Dividend 0.49 USD Ex-Div Date 2024-08-09 Yield 1.48 Div. Freq. SNewsProfileAnalyst Coverage5 Yr. FinancialsDividendsEarningsPrice HistoryEventsInsidersAstraZeneca PLC News Stock Investing News, Analysis and Tips Sep 5, 2023 7:00 AM EDT Is Walgreens so bad it's a buy? Shares slumped on Frid...
Net debt increased by $1 billion to $24 billion, driven by the payment of the second interim dividend in March and $2.4 billion in deal payments, which include the second payment to Acerta made in the first quarter. As a reminder, we will pay the third and final payment in 2024. For...
share comment s (5) recommended for you about azn stock symbol last price % chg 1d 5d 1m 6m 1y 5y 10y market cap pe yield rev growth (yoy) short interest prev. close compare to peers more on azn related stocks symbol last price % chg azn azn - - azncf azncf - - 1d 5d 1m ...
44.35B Most of AstraZeneca PLC's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AstraZeneca...
Annual Yield 0.02 % Five Year Return 3.01 % Net Asset 96.48 B Last Dividend Paid 2.9 About AstraZeneca PLC Fundamental Analysis The Macroaxis Fundamental Analysis modules help investors analyze AstraZeneca PLC's financials across various querterly and yearly statements, indicators and fundamental ...